Elaprase drug
WebDetermine the amount of drug solution needed to provide the dose. The number of needed drug vials is based on the patient's weight in kg times the recommended dose of 0.5 mg/kg. There are 6 mg of idursulfase per vial at a concentration of 2 mg/mL. Round up to determine the number of whole vials needed to provide the dose. WebJun 15, 2009 · Elaprase (idursulfase), a large molecular protein, is not expected to cross the blood brain barrier at therapeutic levels when administered intravenously. A new formulation of idursulfase, idursulfase-IT, that differs from that of the intravenous (IV) formulation, Elaprase, has been developed to be suitable for delivery into the cerebrospinal ...
Elaprase drug
Did you know?
WebJul 13, 2024 · The member either has immunoglobulin A (IgA) deficiency with anti-IgA antibodies† or has developed anti-drug antibodies††† which increases the risk for … WebElaprase (idursulfase) dosing, indications, interactions, adverse effects, and more Drugs & Diseases idursulfase (Rx) Brand and Other Names: Elaprase Classes: Enzymes, …
WebMassHealth Supplemental Rebate/Preferred Drug List. Link to the list of drugs preferred by MassHealth based on supplemental rebate agreements between MassHealth and drug … WebApr 15, 2024 · 3. Elaprase (idursulfase): Elaprase is a medication used to treat a rare genetic disorder called Hunter syndrome, which causes the buildup of certain chemicals in the body. The cost of...
WebFood and Drug Administration Silver Spring MD 20993 BLA 125151/152 . BLA 125151/184 . SUPPLEMENT APPROVAL . ACCELERATED APPROVAL . FULFILLMENT OF POSTMARKETING . ... 2012, submitted under section 351(a) of the Public Health Service Act for Elaprase (idursulfase). We acknowledge receipt of your amendments … WebElaprase 6 Mg/3 Ml Intravenous Solution Metabolic Disease Enzyme Replacement - Mucopolysaccharidosis - Uses, Side Effects, and More Generic Name(S): idursulfase …
WebJan 11, 2024 · Elaprase is an IV infusion used to treat some of the symptoms of a genetic condition called Hunter's syndrome, also called mucopolysaccharidosis (MYOO …
WebDec 5, 2024 · Elaprase is a prescription medicine used to treat symptoms of Hunter Syndrome. Elaprase may be used alone or with other medications. Elaprase belongs to … connect using access pointWebDec 5, 2024 · Elaprase (idursulfase) Solution for Intravenous Infusion is an enzyme used to treat some of the symptoms of a genetic condition called Hunter syndrome (also called … editable look cover write checkWebThe main aim of this study is to evaluate the ability of a prophylactic immune tolerizing regimen (ITR) to prevent or reduce the development of high titer anti-idursulfase antibodies in treatment-naïve participants with Hunter syndrome.. In this open label, single arm study, all participants will receive ELAPRASE treatment and a prophylactic ITR. editable listview vbaWebFeb 4, 2014 · Elaprase, a large molecular protein, is not expected to cross the blood brain barrier when administered intravenously. A revised formulation of idursulfase, idursulfase-IT, that differs from that of the intravenous (IV) formulation, Elaprase, has been developed to be suitable for delivery into the cerebrospinal fluid (CSF) via intrathecal administration. editable lock out tag out formWebElaprase(idursulfase): Hunter syndrome (mucopolysaccharidosis II). IV infusion 0.5 mg/kg body wt every wk over a period of 1-3 hr. Max: 8 hr. Infusion rate: 8 mL/hr for the 1st 15 min, increase by 8 mL/hr increments at 15 min intervals. Max: 100 mL/hr. editable invoice format in word free downloadWebFeb 28, 2024 · In this open label, single arm study, all participants will receive ELAPRASE treatment and a prophylactic ITR. Participants will be treated with ELAPRASE for up to 104 weeks. The prophylactic ITR will start 1 day prior to the start of ELAPRASE. ... Participant has received treatment with any investigational drug within the 30 days prior to ... editable lease agreementWebFeb 11, 2024 · • ELAPRASE is contraindicated in Patients who are hypersensitive to this drug or to any ingredient in the formulation, including any non- medicinal ingredient , or … editable map of oklahoma